Inventor
LI DANSU
US37 patents
⚠️ This page may combine multiple inventors who share the name “LI DANSU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
8 patentsUS7524842B2Apr 28, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP19 citations92
US7504424B2Mar 17, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP24 citations92
US7488745B2Feb 10, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP23 citations92
US7687527B2Mar 30, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP8 citations84
US7879890B2Feb 1, 2011
Compounds for the treatment of inflammatory disorders
SCHERING CORP6 citations73
US7772263B2Aug 10, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP7 citations73
US7683088B2Mar 23, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP1 citations62
US7652020B2Jan 26, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP5 citations62
UNIV CORNELL
8 patentsUS10961218B2Mar 30, 2021
IRE1 small molecule inhibitors
UNIV CORNELL4 citations83
US10745379B2Aug 18, 2020
IRE1 small molecule inhibitors
UNIV CORNELL7 citations83
US11649224B2May 16, 2023
IRE1 small molecule inhibitors
UNIV CORNELL2 citations72
US11634403B2Apr 25, 2023
IRE1 small molecule inhibitors
UNIV CORNELL1 citations72
US11021466B2Jun 1, 2021
IRE1 small molecule inhibitors
UNIV CORNELL3 citations72
US12071424B2Aug 27, 2024
IRE1 small molecule inhibitors
UNIV CORNELL0 citations62
US12479818B2Nov 25, 2025
Treatment of fibrosis with IRE1 small molecule inhibitors
UNIV CORNELL0 citations51
US10934275B2Mar 2, 2021
IRE1 small molecule inhibitors
UNIV CORNELL0 citations51
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
6 patentsUS10376511B2Aug 13, 2019
Pyrazole pyrimidine derivative and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD10 citations81
US10960003B2Mar 30, 2021
Pyrazole pyrimidine derivative and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD4 citations70
US11072599B2Jul 27, 2021
Pyrazole compounds and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD4 citations69
US11999721B2Jun 4, 2024
Pyrazole compounds and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations59
US11925641B2Mar 12, 2024
Pyrazole pyrimidine derivative and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations59
US12514859B2Jan 6, 2026
Pyrazole pyrimidine derivative and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations57
SYROS PHARMACEUTICALS INC
5 patentsUS10106526B2Oct 23, 2018
Inhibitors of cyclin-dependent kinase 7 (CDK7)
SYROS PHARMACEUTICALS INC5 citations83
US10059690B2Aug 28, 2018
Inhibitors of cyclin-dependent kinase 7 (CDK7)
SYROS PHARMACEUTICALS INC9 citations83
US10308648B2Jun 4, 2019
Inhibitors of cyclin-dependent kinase 7 (CDK7)
SYROS PHARMACEUTICALS INC6 citations82
US10519135B2Dec 31, 2019
Inhibitors of cyclin-dependent kinase 7 (CDK7)
SYROS PHARMACEUTICALS INC3 citations72
US10865206B2Dec 15, 2020
Inhibitors of cyclin-dependent kinase 7 (CDK7)
SYROS PHARMACEUTICALS INC1 citations61
MERCK SHARP & DOHME
2 patentsUS9586968B2Mar 7, 2017
Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME2 citations59
US9624208B2Apr 18, 2017
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME1 citations49